Correction to: The impact of COVID-19 on systemic anticancer treatment delivery in Scotland

Br J Cancer. 2021 May;124(10):1745. doi: 10.1038/s41416-021-01298-w.

Mark A Baxter^{1

2}, John Murphy³, David Cameron^{4

5}, Judith Jordan⁶, Christine Crearie⁷, Christina Lilley⁵, Azmat Sadozye⁷, Mary Maclean⁷, Peter Hall^{4

5}, Angela Phillips², Alex Greger⁶, Jude Madeleine⁸, Russell D Petty^{9

10}

¹ Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
² Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK.
³ NHS Lanarkshire, South Lanarkshire, UK.
⁴ Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.
⁵ Edinburgh Cancer Centre, NHS Lothian, Edinburgh, UK.
⁶ NHS Grampian, Aberdeen, UK.
⁷ West of Scotland Cancer Network, Glasgow, UK.
⁸ NHS Highland, Inverness, UK.
⁹ Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK. r.petty@dundee.ac.uk.
¹⁰ Tayside Cancer Centre, Ninewells Hospital and Medical School, NHS Tayside, Dundee, UK. r.petty@dundee.ac.uk.

No abstract available

Publication types